Prompt:
Outside of healthy nutrition and exercise what are currently considered the most effective Longevity measures that are known. Fokus on western male genotypes around 40-50 years old. Substances and supplements that have at least some clinical research with humans. Go deep, but explain the findings also for non-medical people. At the end come up with Longevity stack and treatment protocol.
For Western men aged 40–50, clinical research reveals several longevity interventions that target fundamental aging mechanisms. Metformin shows promise in reducing age-related diseases by activating AMPK pathways, with trials like TAME [1][6] demonstrating reduced morbidity. Rapamycin improves muscle mass and metabolic markers at low doses (5–10 mg/week), particularly in males [2][7]. NAD+ precursors (NMN/NR) enhance insulin sensitivity and cellular energy, supported by multiple human trials confirming safety up to 500 mg/day [3][8][10]. Senolytics (dasatinib + quercetin) reduce senescent cells and inflammation in diabetic kidney disease patients [9][13], while fisetin extends lifespan in preclinical models by clearing damaged cells [4]. Spermidine is well-tolerated and may protect cardiovascular health [5][11], and DHEA supplementation improves body composition and glucose metabolism [12][15]. Urolithin A significantly boosts muscle endurance in elderly trials [17], and CoQ10 with selenium reduces telomere shortening linked to cardiovascular mortality [20]. Resveratrol and alpha-ketoglutarate (Ca-AKG) show preclinical potential but require more human validation [16][18].
Metformin: Repurposing a Diabetes Drug for Longevity
Metformin targets cellular energy pathways implicated in aging. By activating AMPK and reducing mTOR signaling, it mimics calorie restriction effects, potentially delaying age-related diseases [1][6]. The landmark TAME trial (n=3,000) investigates metformin’s ability to postpone multiple age-related conditions like heart disease and cognitive decline in non-diabetics aged 65–79. Early data from the smaller MILES trial showed metformin restored youthful gene expression in muscle and adipose tissue, suggesting systemic anti-aging effects [1][6]. For men 40–50, low-dose metformin (500–850 mg/day) may preemptively combat insulin resistance—a key aging accelerator. Side effects like gastrointestinal discomfort are typically transient, and contraindications include renal impairment [1].
Rapamycin: Balancing mTOR Inhibition and Safety
Originally an immunosuppressant, rapamycin extends lifespan in mice by inhibiting mTOR, a regulator of cell growth and metabolism. Human trials reveal nuanced benefits: The PEARL study (48 weeks, n=100) used 5–10 mg/week doses and observed improved lean mass in women and bone density in men without severe adverse events [2][7]. For middle-aged males, intermittent dosing (e.g., weekly 5 mg) may optimize tissue repair while minimizing immunosuppression risks. Rapamycin’s effects appear sex-specific, with males benefiting more from bone preservation and metabolic modulation [2][7]. Long-term safety beyond one year remains under investigation, but current data support cautious use under medical supervision.
NAD+ Boosters: NMN and NR for Cellular Revitalization
NAD+ decline drives aging by impairing mitochondrial function and DNA repair. NMN and NR (NAD+ precursors) restore these levels, with human trials confirming safety and efficacy. In men with mild cognitive impairment, NR (1 g/day) increased blood NAD+ 2.6-fold and improved cerebral blood flow without cognitive decline [10]. NMN trials (100–500 mg/day) enhanced insulin sensitivity and aerobic capacity within weeks [3][8]. For 40–50-year-olds, NMN may counter age-related metabolic slowdown, though the FDA now regulates it as a drug due to ongoing clinical investigations [3]. NR remains available as a supplement with more extensive human data supporting its use for maintaining muscle and brain health [10][14].
Senolytics: Targeting Zombie Cells
Senescent cells accumulate with age, secreting inflammatory factors that damage tissues. Dasatinib (50 mg) + quercetin (500 mg) for 3 consecutive days/month cleared these cells in diabetic kidney disease patients with no severe side effects [9][13]. Fisetin (500 mg/day) reduced senescence markers in animal models and extended lifespan [4]. Human fisetin trials are limited but show promise for reducing inflammation. Middle-aged males with early metabolic or joint issues may benefit from quarterly D+Q cycles to preempt age-related chronic inflammation. Ongoing trials are testing fisetin’s effects on osteoarthritis and frailty [13].
Hormonal Interventions: DHEA and Spermidine
DHEA levels drop 80% by age 75, correlating with frailty. Supplementation (50 mg/day) improved insulin sensitivity and reduced abdominal fat in elderly humans, particularly in those with baseline deficiencies [12][15]. For men 40–50, DHEA may preserve muscle mass and metabolic flexibility. Spermidine, an autophagy inducer, is safe at 1–3 mg/day but showed no significant cognitive benefits in a year-long trial [11]. However, it reduced inflammatory markers, suggesting utility for cardiovascular health maintenance when initiated early [5].
Emerging Candidates: Urolithin A, CoQ10, and Beyond
Urolithin A (500–1,000 mg/day) improved muscle endurance in elderly trials by enhancing mitochondrial function [17]. CoQ10 (200 mg/day) combined with selenium reduced telomere shortening—a biomarker of aging—and lowered cardiovascular mortality in older adults [20]. Resveratrol improved memory in overweight seniors but may interfere with exercise benefits [16]. Alpha-ketoglutarate is under investigation for reducing epigenetic age, with preliminary data showing safety [18].